The WK HemOnc group is one of the busiest community oncology programs in the region, adding approximately 100 new patients per week with one partner's hematology panel already booked out more than three months. The incoming physician begins as an inpatient oncology hospitalist at Piermont Hospital under a separate contract, then transitions into the main outpatient group at the Cancer Center. This proforma models the outpatient Cancer Center contract at full production. The experienced base of $700,000 sits well above the MGMA 90th percentile for total compensation in this specialty ($963,846 at 90th), providing an exceptionally strong income guarantee. The incentive threshold, calculated from the base and conversion factor, sits at approximately the 90th percentile of wRVU production nationally, meaning the base salary functions as the primary compensation vehicle with incentive reserved for the highest producers. Senior partners in this group have stated that top physicians can exceed the MGMA 90th percentile in total earnings.
*This model includes assumed and/or estimated inputs where data was not provided. Assumptions are clearly marked. Final compensation details are to be confirmed by the employer.
| Variable | Value |
|---|---|
| Clinical Days per Week | 4* |
| Clinical Hours per Week | 32* |
| Patients per Day | 25* |
| Weeks Worked | 46* |
| Base Salary — Experienced | $700,000 |
| Base Salary — New Graduate | $620,000 |
| Conversion Factor — Experienced | $61.00 per wRVU |
| Conversion Factor — New Graduate | $60.00 per wRVU |
| Incentive Threshold — Experienced | 11,475 wRVUs* (Base ÷ CF = $700,000 ÷ $61) |
| Incentive Threshold — New Graduate | 10,333 wRVUs* (Base ÷ CF = $620,000 ÷ $60) |
| wRVU per Visit | 1.47* (MGMA median total wRVU ÷ estimated annual visits) |
| Affiliation Bonus | $25,000 over 3 years or $50,000 over 5 years |
| Relocation | $10,000 |
Note: HemOnc wRVU production is substantially augmented by infusion and chemotherapy administration codes beyond standard E&M visits. Physicians overseeing infusions until completion, as is the practice at this group, may generate wRVUs materially above what a per-visit estimate captures. MGMA benchmarks are used as the primary production reference.
| Variable | Formula | Value |
|---|---|---|
| Annual Visits | 4 days × 25 pts × 46 weeks | 4,600 visits* |
| Total wRVUs — Assumed Schedule | 4,600 × 1.47 wRVU/visit | 6,762 wRVUs* |
| Total wRVUs — MGMA Median | MGMA HemOnc Overall Median | 6,393 wRVUs* |
| Total wRVUs — MGMA 75th Percentile | MGMA HemOnc Overall 75th | 8,564 wRVUs* |
| Total wRVUs — MGMA 90th Percentile | MGMA HemOnc Overall 90th | 11,555 wRVUs* |
Experienced Physician | Base: $700,000 | Threshold: 11,475 wRVUs* | CF: $61
| Scenario | Total wRVUs | Incentive Formula | Incentive | Total Compensation |
|---|---|---|---|---|
| MGMA Median (6,393*) | 6,393* | Below threshold | $0 | $700,000 |
| MGMA 75th (8,564*) | 8,564* | Below threshold | $0 | $700,000 |
| MGMA 90th (11,555*) | 11,555* | (11,555 – 11,475) × $61 | $4,880* | $704,880* |
| High Producer (14,000*) | 14,000* | (14,000 – 11,475) × $61 | $154,025* | $854,025* |
New Graduate | Base: $620,000 | Threshold: 10,333 wRVUs* | CF: $60
| Scenario | Total wRVUs | Incentive Formula | Incentive | Total Compensation |
|---|---|---|---|---|
| MGMA Median (6,393*) | 6,393* | Below threshold | $0 | $620,000 |
| MGMA 90th (11,555*) | 11,555* | (11,555 – 10,333) × $60 | $73,320* | $693,320* |
| High Producer (14,000*) | 14,000* | (14,000 – 10,333) × $60 | $220,020* | $840,020* |